[H]C12CC1([H])C1(C)C(=CC2=O)C(Cl)=CC2([H])C3([H])CCC(OC(C)=O)(C(C)=O)C3(C)CCC21[H]
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?